Person who experienced the adverse event (patient)
| Event ID | CASE | I F COD | FOLL SEQ | IMAGE | EVENT DT | MFR DT | FDA DT | REPT COD | MFR NUM | MFR SNDR | AGE | AGE COD | GNDR COD | E SUB | WT | WT COD | REPT DT | OCCP COD | DEATH DT | TO MFR | CONFID | REPORTER COUNTRY |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 8016640 | 8233293 | F | 8016640-7 | 20111024 | 20111209 | 20111231 | PER | US-ROXANE LABORATORIES, INC.-2011-RO-01529RO | ROXANE LABORATORIES, INC. | 41 | YR | F | Y | 20111231 | OT | UNITED STATES |
Drug(s) used by person
| Event ID | DRUG SEQ | ROLE COD | DRUGNAME | VAL VBM | ROUTE | DOSE VBM | DECHAL | RECHAL | LOT NUM | EXP DT | NDA NUM |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 8016640 | 1018419968 | PS | CYCLOPHOSPHAMIDE | 1 | ORAL | 50 MG | 159897A | 040032 | |||
| 8016640 | 1018419969 | C | AMBIEN | 1 | |||||||
| 8016640 | 1018419970 | C | PERCOCET | 1 | |||||||
| 8016640 | 1018419971 | C | VITAMIN D | 1 |
Indications of drugs used
| Event ID | DRUG SEQ | INDI PT |
|---|---|---|
| 8016640 | 1018419968 | BREAST CANCER STAGE IV |
Outcome of event
| no results found |
Reactions reported
| Event ID | PT |
|---|---|
| 8016640 | VOMITING |
| 8016640 | NAUSEA |
| 8016640 | TABLET PHYSICAL ISSUE |
| 8016640 | RETCHING |
Reporting Sources (this data is often not reported and may therefore be missing here)
| no results found |
Therapies reported
| Event ID | DRUG SEQ | START DT | END DT | DUR | DUR COD |
|---|---|---|---|---|---|
| 8016640 | 1018419968 | 20111018 |